Epidermal Hyaluronan in Barrier Alteration-Related Disease

In skin, although the extracellular matrix (ECM) is highly developed in dermis and hypodermis, discrete intercellular spaces between cells of the living epidermal layers are also filled with ECM components. Herein, we review knowledge about structure, localization and role of epidermal hyaluronan (H...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Céline Evrard, Catherine Lambert de Rouvroit, Yves Poumay
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/4533df450a2d48a1866f9177d0c9f06c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4533df450a2d48a1866f9177d0c9f06c
record_format dspace
spelling oai:doaj.org-article:4533df450a2d48a1866f9177d0c9f06c2021-11-25T17:11:27ZEpidermal Hyaluronan in Barrier Alteration-Related Disease10.3390/cells101130962073-4409https://doaj.org/article/4533df450a2d48a1866f9177d0c9f06c2021-11-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/3096https://doaj.org/toc/2073-4409In skin, although the extracellular matrix (ECM) is highly developed in dermis and hypodermis, discrete intercellular spaces between cells of the living epidermal layers are also filled with ECM components. Herein, we review knowledge about structure, localization and role of epidermal hyaluronan (HA), a key ECM molecule. HA is a non-sulfated glycosaminoglycan non-covalently bound to proteins or lipids. Components of the basal lamina maintain some segregation between the epidermis and the underlying dermis, and all epidermal HA is locally synthesized and degraded. Functions of HA in keratinocyte proliferation and differentiation are still controversial. However, through interactions with partners, such as the TSG-6 protein, HA is involved in the formation, organization and stabilization of the epidermal ECM. In addition, epidermal HA is involved in the formation of an efficient epidermal barrier made of cornified keratinocytes. In atopic dermatitis (AD) with profuse alterations of the epidermal barrier, HA is produced in larger amounts by keratinocytes than in normal skin. Epidermal HA inside AD lesional skin is located in enlarged intercellular spaces, likely as the result of disease-related modifications of HA metabolism.Céline EvrardCatherine Lambert de RouvroitYves PoumayMDPI AGarticlehyaluronanepidermal extracellular matrixatopic dermatitisBiology (General)QH301-705.5ENCells, Vol 10, Iss 3096, p 3096 (2021)
institution DOAJ
collection DOAJ
language EN
topic hyaluronan
epidermal extracellular matrix
atopic dermatitis
Biology (General)
QH301-705.5
spellingShingle hyaluronan
epidermal extracellular matrix
atopic dermatitis
Biology (General)
QH301-705.5
Céline Evrard
Catherine Lambert de Rouvroit
Yves Poumay
Epidermal Hyaluronan in Barrier Alteration-Related Disease
description In skin, although the extracellular matrix (ECM) is highly developed in dermis and hypodermis, discrete intercellular spaces between cells of the living epidermal layers are also filled with ECM components. Herein, we review knowledge about structure, localization and role of epidermal hyaluronan (HA), a key ECM molecule. HA is a non-sulfated glycosaminoglycan non-covalently bound to proteins or lipids. Components of the basal lamina maintain some segregation between the epidermis and the underlying dermis, and all epidermal HA is locally synthesized and degraded. Functions of HA in keratinocyte proliferation and differentiation are still controversial. However, through interactions with partners, such as the TSG-6 protein, HA is involved in the formation, organization and stabilization of the epidermal ECM. In addition, epidermal HA is involved in the formation of an efficient epidermal barrier made of cornified keratinocytes. In atopic dermatitis (AD) with profuse alterations of the epidermal barrier, HA is produced in larger amounts by keratinocytes than in normal skin. Epidermal HA inside AD lesional skin is located in enlarged intercellular spaces, likely as the result of disease-related modifications of HA metabolism.
format article
author Céline Evrard
Catherine Lambert de Rouvroit
Yves Poumay
author_facet Céline Evrard
Catherine Lambert de Rouvroit
Yves Poumay
author_sort Céline Evrard
title Epidermal Hyaluronan in Barrier Alteration-Related Disease
title_short Epidermal Hyaluronan in Barrier Alteration-Related Disease
title_full Epidermal Hyaluronan in Barrier Alteration-Related Disease
title_fullStr Epidermal Hyaluronan in Barrier Alteration-Related Disease
title_full_unstemmed Epidermal Hyaluronan in Barrier Alteration-Related Disease
title_sort epidermal hyaluronan in barrier alteration-related disease
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/4533df450a2d48a1866f9177d0c9f06c
work_keys_str_mv AT celineevrard epidermalhyaluronaninbarrieralterationrelateddisease
AT catherinelambertderouvroit epidermalhyaluronaninbarrieralterationrelateddisease
AT yvespoumay epidermalhyaluronaninbarrieralterationrelateddisease
_version_ 1718412645141315584